Global Vaccine Adjuvants Market to Reach USD 1.6 Billion By 2027

 


Vaccine Adjuvants Market is projected to grow from USD 1.5 billion in 2022 to USD 1.6 billion by 2027, at a CAGR of 1.7% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth of the market is projected to be driven by collaborations and partnerships among market players for the development of vaccine adjuvants, an increasing number of COVID-19 vaccines in the development pipeline and increasing focus on immunization programs.

What are Vaccine Adjuvants and What Do They Do?

Vaccine adjuvants are substances added to vaccines to boost their efficacy. They work by stimulating the body’s immune system to produce a stronger immune response after vaccination. By doing so, adjuvants can help the body recognize and fight off the disease. Vaccine adjuvants can also extend the duration of protection, reduce the number of doses needed, and help protect against emerging and reemerging diseases.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=152603894

What Factors are Driving Growth in the Vaccine Adjuvants Market?

The vaccine adjuvants market is growing rapidly due to the increasing demand for safer and more effective vaccines, advancements in adjuvant technologies, and a growing awareness of the importance of immunization. The emergence of new and re-emerging infectious diseases, such as COVID-19, has also increased the demand for adjuvants. Additionally, the increasing prevalence of chronic diseases, such as cancer and diabetes, has prompted the development of new adjuvants for therapeutic vaccines. Finally, the rise in government funding for vaccine development and the increasing investments from pharmaceutical companies are also contributing to the growth of the vaccine adjuvants market.

What are the Different Types of Vaccine Adjuvants?

Vaccine adjuvants can be divided into two categories: chemical and biological. Chemical adjuvants include aluminum salts, such as aluminum hydroxide and aluminum phosphate; synthetic compounds, such as squalene and polysorbates; and oil-in-water emulsions, such as MF59 and AS03. Biological adjuvants include bacteria, viruses, and plant extracts.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=152603894

What are the Key Players in the Vaccine Adjuvants Market?

The vaccine adjuvants market is highly competitive, with several key players. Key players in the vaccine adjuvants market include GSK plc (UK), Dynavax Technologies (US), Novavax (US), Agenus Inc. (US), Croda International plc (UK), Seppic (France), OZ Biosciences (US), Phibro Animal Health Corporation (US), Associated British Foods plc (UK), InvivoGen (US), Merck KGaA (Germany), CSL Limited (Australia), Vertellus (US), Allergy Therapeutics (UK), Riboxx GmbH (Germany), CaPtivatϵ Pharmaceuticals LLC (US), EuBiologics Co., Ltd. (South Korea), Pacific GeneTech Limited (US), Hawaii Biotech Inc. (US), and Vaxine Pty Ltd. (Australia).

What are the Future Trends in the Vaccine Adjuvants Market?

The vaccine adjuvants market is expected to continue to grow in the coming years due to the emergence of new and re-emerging infectious diseases, the increasing prevalence of chronic diseases, and advancements in adjuvant technologies. Additionally, the development of combination vaccines, as well as the increasing demand for personalized vaccines, is also expected to drive growth in the market. The increasing investments in vaccine research and development, and the rise in government funding for vaccine development are expected to further boost the growth of the vaccine adjuvants market.

This report categorizes the vaccine adjuvants market into the following segments and subsegments

By Product

  • Adjuvant Emulsions
  • Pathogen Components
  • Saponin-baased adjuvants
  • Particulate Adjuvants
  • Other Adjuvants

By Route of Administration

  • Intramuscular
  • Subcutaneous
  • Other Route of Administration

By Disease Type

  • Infectious Diseases
  • Cancer
  • Others

By Application

  • Research Applications
  • Commercial Applications

By Application Category

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Recent Developments

  • Dynavax Technologies (US) entered into a fully funded collaboration with the US Department of Defense to conduct a Phase 2 clinical trial for a plague vaccine adjuvanted with CpG 1018.
  • SK Bioscience (South Korea)and GSK plc (UK)entered into a collaboration for COVID-19 vaccine development.

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=152603894

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Comments

Post a Comment

Popular posts from this blog

Human Microbiome Market Forecast 2025–2031: Driving Healthcare Innovation

Image
  Why the Human Microbiome Matters in 2025 The human microbiome —the trillions of microorganisms living inside the human body—is no longer just a topic for researchers. In 2025, it stands at the center of healthcare innovation , reshaping how we approach precision medicine, gut health, and therapeutic development . From microbiome-based therapies to diagnostics and probiotics, this rapidly expanding sector is capturing the attention of investors, biotech firms, and healthcare providers worldwide . According to the latest market research, the global human microbiome market, valued at US$0.91 billion in 2024, rose to US$1.40 billion in 2025 . It is projected to advance at a remarkable CAGR of 31.0% from 2025 to 2031 , culminating in an estimated US$7.09 billion by 2031 . This explosive growth highlights the increasing relevance of microbiome research in shaping the future of medicine . Download PDF Brochure:  Market Growth Insights & Trends The human microbiome ma...
Read more

Empty Capsules Market Trends and Competitive Analysis - Exclusive Report by MarketsandMarkets™

Image
  The newly released exclusive study titled "Empty Capsules Market" guarantees that you will be better informed than your competitors. This study provides a comprehensive perspective of the market along with in-depth market insight and analysis that makes survival and success in the market easier. The market report presents the best market and business solutions for the Compound Management industry in this increasingly revolutionary market. Browse and in-depth TOC on "Empty Capsules Market" 176 - Tables 40 - Figures 216 - Pages Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=218018190 According to the new market research report "Empty Capsules Market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. Some of the Leading Players in the Empty Capsules Market The prominent players operating in the Empty Capsules Market are Capsugel (US), ACG World...
Read more

Sterilization Services Market worth $5.49 billion by 2030

Image
  The report  " Sterilization Services Market  by Method (Electron Beam, EtO, Steam, Gamma, X-Ray, Hydrogen Peroxide), Type (Contract Sterilization, Validation Services), Mode of Delivery (Off-Site, On-Site), End User & Region - Global Forecast to 2030" , is projected to reach USD 5.49 billion by 2030 from USD 3.75 billion in 2025, at a CAGR of 7.9% during the forecast period. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183597324 The market for sterilization services is growing due to several factors, including the rising prevalence of hospital-acquired infections (HAIs), increasing surgical procedure volumes, heightened focus on food sterilization to combat foodborne illnesses, and the growing trend of outsourcing sterilization to specialized contract service providers. Additionally, stricter regulatory requirements for sterile packaging in the pharmaceutical and medical device sectors are further fueling market demand. By ...
Read more